Globus Medical Inc
GMED57.900USD
+0.060+0.10%
交易中 （美东）报价延迟15分钟
7.82B总市值
21.92市盈率 TTM
关于 Globus Medical Inc 公司
Globus Medical, Inc. 是一家医疗设备公司，致力于开发和商业化医疗保健解决方案，重点是改善肌肉骨骼疾病患者的生活质量。该公司提供一系列差异化技术，用于治疗各种肌肉骨骼疾病。肌肉骨骼解决方案主要包括用于一系列脊柱、骨科和神经外科手术的植入式设备、生物制剂、配件和手术器械。其脊柱产品可解决影响脊柱的大多数疾病，包括退行性疾病、畸形、肿瘤和创伤。该公司提供的解决方案可促进开放式和微创手术 (MIS) 技术。它包括传统的融合植入物，例如椎弓根螺钉和杆系统。其骨科创伤解决方案旨在治疗各种骨科骨折模式和上肢和下肢以及髋部的患者解剖结构。
公司简介
公司代码GMED
公司名称Globus Medical Inc
上市日期Mar 08, 2012
CEOMr. Keith W. Pfeil
员工数量5300
证券类型Ordinary Share
年结日Mar 08
公司地址2560 General Armistead Ave
城市AUDUBON
上市交易所NYSE Consolidated
国家United States of America
邮编19403
电话16109301800
网址https://www.globusmedical.com/
公司代码GMED
上市日期Mar 08, 2012
CEOMr. Keith W. Pfeil
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
35.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
Mr. Stephen T. (Steve) Zarrilli
Mr. Stephen T. (Steve) Zarrilli
Independent Director
Independent Director
--
--
Mr. James R. Tobin
Mr. James R. Tobin
Independent Director
Independent Director
--
--
Ms. Kelly Grace Huller, J.D.
Ms. Kelly Grace Huller, J.D.
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
--
--
Dr. John A. Deford, Ph.D.
Dr. John A. Deford, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
-6.86%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
35.38K
--
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
16.42K
--
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Brian Kearns
Mr. Brian Kearns
Investor Relations
Investor Relations
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Musculoskeletal Solutions
575.93M
96.29%
Musculoskeletal Solutions products
575.93M
96.29%
Enabling Technologies
22.19M
3.71%
Enabling Technologies products
22.19M
3.71%
地区USD
名称
营收
占比
United States
483.86M
80.90%
International
114.26M
19.10%
业务
地区
业务USD
名称
营收
占比
Musculoskeletal Solutions
575.93M
96.29%
Musculoskeletal Solutions products
575.93M
96.29%
Enabling Technologies
22.19M
3.71%
Enabling Technologies products
22.19M
3.71%
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.49%
BlackRock Institutional Trust Company, N.A.
8.71%
Janus Henderson Investors
7.29%
Burgundy Asset Management Ltd.
3.09%
State Street Global Advisors (US)
3.08%
其他
68.34%
持股股东
持股股东
占比
The Vanguard Group, Inc.
9.49%
BlackRock Institutional Trust Company, N.A.
8.71%
Janus Henderson Investors
7.29%
Burgundy Asset Management Ltd.
3.09%
State Street Global Advisors (US)
3.08%
其他
68.34%
股东类型
持股股东
占比
Investment Advisor
51.77%
Investment Advisor/Hedge Fund
35.75%
Hedge Fund
10.02%
Pension Fund
1.99%
Research Firm
1.43%
Sovereign Wealth Fund
1.07%
Bank and Trust
1.07%
Individual Investor
0.69%
Private Equity
0.29%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
1034
115.30M
102.09%
-12.49M
2025Q1
1057
115.54M
102.35%
-11.15M
2024Q4
1031
113.94M
83.15%
-12.71M
2024Q3
978
112.33M
98.84%
-21.04M
2024Q2
969
117.21M
103.71%
-15.66M
2024Q1
950
117.87M
104.30%
-9.50M
2023Q4
917
111.19M
96.81%
-13.25M
2023Q3
911
113.44M
96.67%
+12.22M
2023Q2
864
84.90M
108.73%
-4.84M
2023Q1
857
78.38M
100.58%
-6.61M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
10.88M
9.64%
+45.25K
+0.42%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
9.87M
8.73%
+23.63K
+0.24%
Mar 31, 2025
Janus Henderson Investors
7.01M
6.2%
+391.41K
+5.92%
Mar 31, 2025
Burgundy Asset Management Ltd.
2.80M
2.48%
+183.64K
+7.01%
Mar 31, 2025
State Street Global Advisors (US)
3.62M
3.2%
+21.05K
+0.59%
Mar 31, 2025
JP Morgan Asset Management
2.45M
2.17%
-176.33K
-6.72%
Mar 31, 2025
Sculptor Capital Management, Inc
2.09M
1.85%
+15.00K
+0.72%
Mar 31, 2025
William Blair Investment Management, LLC
2.27M
2.01%
+1.04M
+84.46%
Mar 31, 2025
Hawk Ridge Capital Management LP
1.68M
1.49%
+4.56K
+0.27%
Mar 31, 2025
Geneva Capital Management LLC
1.83M
1.62%
+17.81K
+0.98%
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月6日 周六
更新时间: 9月6日 周六
机构名称
占比
First Trust Indxx Medical Devices ETF
1.62%
ProShares MSCI Transformational Changes ETF
0.2%
Strive 1000 Growth ETF
0.01%
AvantisUS Mid Cap Value ETF
0.01%
Vanguard US Momentum Factor ETF
0%
Vanguard S&P Mid-Cap 400 Value Index Fund
0%
Inspire Small/Mid Cap ESG ETF
0%
John Hancock Multifactor Small Cap ETF
0%
First Trust Mid Cap Core Alphadex Fund
0%
First Trust Mid Cap Value AlphaDEX Fund
0%
查看更多
First Trust Indxx Medical Devices ETF
占比1.62%
ProShares MSCI Transformational Changes ETF
占比0.2%
Strive 1000 Growth ETF
占比0.01%
AvantisUS Mid Cap Value ETF
占比0.01%
Vanguard US Momentum Factor ETF
占比0%
Vanguard S&P Mid-Cap 400 Value Index Fund
占比0%
Inspire Small/Mid Cap ESG ETF
占比0%
John Hancock Multifactor Small Cap ETF
占比0%
First Trust Mid Cap Core Alphadex Fund
占比0%
First Trust Mid Cap Value AlphaDEX Fund
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
